Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 223

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Metformin attenuates ovarian cancer cell growth in an AMP‐kinase dispensable manner

Open access
Rattan, R., Giri, S., Hartmann, L.C., Shridhar, V.·2011·Journal of Cellular and Molecular Medicine

Abstract

Metformin, the most widely used drug for type 2 diabetes activates 59 adenosine monophosphate (AMP)‐activated protein kinase (AMPK), which regulates cellular energy metabolism. Here, we report that ovarian cell lines VOSE, A2780, CP70, C200, OV202, OVCAR3, SKOV3ip, PE01 and PE04 predominantly express ‐α 1 , ‐β 1 , ‐γ 1 and ‐γ 2 isoforms of AMPK subunits. Our studies show that metformin treatment (1) significantly inhibited proliferation of diverse chemo‐responsive and ‐resistant ovarian cancer cell lines (A2780, CP70, C200, OV202, OVCAR3, SKVO3ip, PE01 and PE04), (2) caused cell cycle arrest accompanied by decreased cyclin D1 and increased p21 protein expression, (3) activated AMPK in various ovarian cancer cell lines as evident from increased phosphorylation of AMPKα and its downstream substrate; acetyl co‐carboxylase (ACC) and enhanced β‐oxidation of fatty acid and (4) attenuated mTOR‐S6RP phosphorylation, inhibited protein translational and lipid biosynthetic pathways, thus implicating metformin as a growth inhibitor of ovarian cancer cells. We also show that metformin‐mediated effect on AMPK is dependent on liver kinase B1 (LKB1) as it failed to activate AMPK‐ACC pathway and cell cycle arrest in LKB1 null mouse embryo fibroblasts (mefs). This observation was further supported by using siRNA approach to down‐regulate LKB1 in ovarian cancer cells. In contrast, met formin inhibited cell proliferation in both wild‐type and AMPKα 1/2 null mefs as well as in AMPK silenced ovarian cancer cells. Collectively, these results provide evidence on the role of metformin as an anti‐proliferative therapeutic that can act through both AMPK‐dependent as well as AMPK‐independent pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2009.00954.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 36

  1. 10.3322/canjclin.55.1.10 · DOI · Paper page
  2. 10.3322/CA.2007.0010 · DOI · Paper page
  3. 10.1007/s00018-007-7080-4 · DOI · Paper page
  4. 10.1158/1940-6207.CAPR-08-0081 · DOI · Paper page
  5. 10.1016/j.ygyno.2008.04.008 · DOI · Paper page
  6. 10.1158/0008-5472.CAN-09-0418 · DOI · Paper page
  7. 10.1136/gut.51.suppl_5.v21 · doi:10.1136/gut.51.suppl_5.v21
  8. 10.1146/annurev.pharmtox.47.120505.105304 · DOI · Paper page
  9. 10.1038/ijo.2008.116 · DOI · Paper page
  10. 10.1007/s00018-008-8244-6 · DOI · Paper page
  11. 10.1113/jphysiol.2006.108324 · DOI · Paper page
  12. 10.1074/jbc.M507443200 · DOI · Paper page
  13. 10.1006/excr.1997.3861 · DOI
  14. 10.1046/j.1471-4159.1998.71010078.x · DOI
  15. 10.1111/j.1471-4159.2008.05279.x · DOI
  16. 10.1111/j.1748-1716.2009.01973.x · DOI
  17. 10.1016/S0960-9822(02)01077-1 · DOI · Paper page
  18. 10.1249/01.mss.0000233796.16411.13 · DOI
  19. 10.1016/S1097-2765(02)00568-3 · DOI · Paper page
  20. 10.1002/j.1460-2075.1990.tb07420.x · DOI · Paper page
  21. 10.1111/j.1432-1033.1988.tb14201.x · DOI · Paper page
  22. 10.1038/sj.onc.1207721 · DOI · Paper page
  23. 10.1158/0008-5472.CAN-07-2310 · DOI · Paper page
  24. 10.1158/0008-5472.CAN-08-2641 · DOI
  25. 10.1074/jbc.M610101200 · DOI
  26. 10.1016/j.molcel.2005.03.027 · DOI · Paper page
  27. 10.1158/0008-5472.CAN-06-4447 · DOI · Paper page
  28. Debernardis D, 1997, p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel, Cancer Res, 57, 870
  29. Yu D, 1993, Enhanced c‐erbB‐2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A, Cancer Res, 53, 891
  30. 10.1128/MCB.01621-07 · DOI
  31. 10.1074/jbc.M009953200 · DOI · Paper page
  32. 10.1158/0008-5472.CAN-07-0762 · DOI
  33. 10.1158/0008-5472.CAN-06-0999 · DOI
  34. 10.1093/hmg/11.13.1497 · DOI · Paper page
  35. 10.1016/S0899-9007(99)00266-X · DOI · Paper page
  36. 10.1158/1055-9965.EPI-08-0871 · DOI

Cited by

See all 223

Metadata

Authors
Rattan, R., Giri, S., Hartmann, L. C., & Shridhar, V.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2011-01
Volume
15
Issue
1
Pages
166-178
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W2013374433
Cited by
223
References
8
FWCI
4.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin attenuates ovarian cancer cell growth in an AMP‐kinase dispensable manner. https://app.cochat.ai/papers/10.1111/j.1582-4934.2009.00954.x
The paper
Rattan, R., Giri, S., Hartmann, L. C., & Shridhar, V. (2011). Metformin attenuates ovarian cancer cell growth in an AMP‐kinase dispensable manner. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2009.00954.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.